• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The diagnosis of primary progressive multiple sclerosis.

作者信息

Wolinsky Jerry S

机构信息

Department of Neurology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.

出版信息

J Neurol Sci. 2003 Feb 15;206(2):145-52. doi: 10.1016/s0022-510x(02)00346-5.

DOI:10.1016/s0022-510x(02)00346-5
PMID:12559502
Abstract

Primary progressive multiple sclerosis (PPMS) is a rather unique form of the more common relapsing inflammatory demyelinative disease. The absence of attacks that typify relapsing forms of MS imposes special challenges for diagnosis, but also provides an opportunity to study the pathogenesis of the more progressive aspects of the disease process in isolation of confounding transient clinical events. In this review, recent advances in diagnostic approaches are considered in relationship to baseline data from a large multinational study designed to better characterize and treat this clinical phenotype. PPMS subjects with cerebral spinal fluid (CSF) findings consistent with intrathecal immunoglobulin production may have a more tissue destructive disease process than those whose CSF lacks evidence of a B-cell immunopathogenic disease component.

摘要

相似文献

1
The diagnosis of primary progressive multiple sclerosis.
J Neurol Sci. 2003 Feb 15;206(2):145-52. doi: 10.1016/s0022-510x(02)00346-5.
2
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.原发性进行性多发性硬化症的诊断标准:立场文件。
Ann Neurol. 2000 Jun;47(6):831-5.
3
Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.
Mult Scler. 2004 Jun;10 Suppl 1:S2-7. doi: 10.1191/1352458504ms1024oa.
4
A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.对 McDonald 2010 年原发性进展型多发性硬化诊断标准的一项修正建议。
Mult Scler. 2013 Jul;19(8):1095-100. doi: 10.1177/1352458512464829. Epub 2012 Nov 6.
5
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.原发性进行性多发性硬化症的诊断标准:再评价。
Mult Scler. 2009 Dec;15(12):1459-65. doi: 10.1177/1352458509348422. Epub 2009 Dec 7.
6
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.蛋白质组模式分析可区分多发性硬化相关疾病。
Ann Neurol. 2012 May;71(5):614-23. doi: 10.1002/ana.22633.
7
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.多发性硬化症的蛋白质生物标志物:不同形式多发性硬化症脑脊液候选蛋白生物标志物的半定量分析。
Mult Scler. 2012 Aug;18(8):1081-91. doi: 10.1177/1352458511433303. Epub 2012 Jan 17.
8
The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis.脑和脊髓的磁共振成像(MRI)以及脑脊液检查在原发性进行性多发性硬化症诊断中的作用。
Eur J Neurol. 2007 Nov;14(11):1292-5. doi: 10.1111/j.1468-1331.2007.01932.x. Epub 2007 Aug 31.
9
Diagnosis and management of primary progressive multiple sclerosis.
Minerva Med. 2008 Apr;99(2):141-55.
10
Primary progressive multiple sclerosis: cerebrospinal fluid considerations.原发性进行性多发性硬化症:脑脊液相关考量
Mult Scler. 2004 Jun;10 Suppl 1:S31-4; discussion S34-5. doi: 10.1191/1352458504ms1028oa.

引用本文的文献

1
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers.使用客观分类器对五个欧洲登记处中继发进展型多发性硬化症的比例及特征进行研究。
Mult Scler J Exp Transl Clin. 2023 Feb 16;9(1):20552173231153557. doi: 10.1177/20552173231153557. eCollection 2023 Jan-Mar.
2
Evaluation of CSF kappa free light chains for the diagnosis of multiple sclerosis (MS): a comparison with oligoclonal bands (OCB) detection via isoelectric focusing (IEF) coupled with immunoblotting.脑脊液游离轻链 κ 对多发性硬化症(MS)的诊断评估:与等电聚焦(IEF)结合免疫印迹检测寡克隆带(OCB)的比较。
J Clin Pathol. 2023 May;76(5):353-356. doi: 10.1136/jcp-2022-208354. Epub 2022 Sep 21.
3
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis.
早发型和晚发型多发性硬化症中的诊断性脑脊液生物标志物
Biomedicines. 2022 Jul 7;10(7):1629. doi: 10.3390/biomedicines10071629.
4
Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course.进行性起病的多发性硬化症:病程中有无复发患者的人口统计学、临床和实验室特征
Noro Psikiyatr Ars. 2019 Mar;56(1):23-26. doi: 10.5152/npa.2017.19269. Epub 2018 Jul 4.
5
Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.细胞因子信号传导在多发性硬化症中的作用及其治疗应用
Med Sci (Basel). 2017 Oct 13;5(4):23. doi: 10.3390/medsci5040023.
6
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.进行性阶段的发病是多发性硬化症中一个与年龄相关的临床里程碑。
Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26.
7
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.醋酸格拉替雷治疗多发性硬化症:作用机制的新观点。
CNS Drugs. 2011 May;25(5):401-14. doi: 10.2165/11588120-000000000-00000.
8
[Revision of McDonald's new diagnostic criteria for multiple sclerosis].[麦克唐纳多发性硬化症新诊断标准的修订]
Nervenarzt. 2006 Oct;77(10):1235, 1237-45. doi: 10.1007/s00115-006-2127-6.
9
Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis.原发性进行性多发性硬化症患者主动和被动踝关节运动的功能反应及其临床相关性
J Neurol. 2006 Jul;253(7):882-91. doi: 10.1007/s00415-006-0125-z. Epub 2006 Apr 20.
10
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.多发性硬化标准化磁共振成像方案:多发性硬化中心联盟共识指南
AJNR Am J Neuroradiol. 2006 Feb;27(2):455-61.